Both TREM2, an important component of the DAM phenotype which signals via TYROBP and is an AD GWAS risk factor gene, and TLR4 are increased in the putamen of HD patients and, importantly, are genetic modifiers of HD. This evidence concerns the gene TYROBP and Huntington disease.